BioCentury | Oct 17, 2020
Product Development

How the PanCAN master protocol could promote innovation in pancreatic cancer

...more patients, in the process. On Tuesday, the Pancreatic Cancer Action Network...
...real value to companies,” said Fleshman. Lauren Martz Tyme Inc. Pancreatic Cancer Action Network Cancer Pancreatic...
BioCentury | Apr 26, 2019
Product Development

For patients’ sake, collaborate already

...Leukemia & Lymphoma Society (LLS), Rye Brooke, N.Y. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Pancreatic Cancer Action Network...
BioCentury | Mar 23, 2019
Tools & Techniques

A frequentist and a Bayesian walk into a trial

...way we write regulatory policy.” I-SPY, the Global Coalition for Adaptive Research (GCAR) and the Pancreatic Cancer Action Network...
...Inc., Cambridge, Mass. Innovative Medicines Initiative (IMI), Brussels, Belgium Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pancreatic Cancer Action Network...
...endothelial growth factor receptor 2 Karen Tkach Tuzman, Associate Editor Bayer AG European Medicines Agency (EMA) Innovative Medicines Initiative (IMI) Pancreatic Cancer Action Network U.S...
BioCentury | Mar 15, 2019
Product Development

Broadening the PARP playing field

...POLO trial results as well,” he added. Victoria Manax, CMO at the patient advocacy organization Pancreatic Cancer Action Network...
BioCentury | Sep 21, 2018
Tools & Techniques

Precision for pancreatic cancer

...free-of-charge and match them to existing trials. The platform has a five-day turnaround, Rhodes said. Pancreatic Cancer Action Network...
...N.J. National Center for Tumor Diseases Heidelberg, Heidelberg, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pancreatic Cancer Action Network...
...TMEM66) - Store-operated calcium entry associated regulatory factor Allison Johnson, Staff Writer Cold Spring Harbor Laboratory Dana-Farber Cancer Institute Pancreatic Cancer Action Network Strata...
BioCentury | May 18, 2018
Company News

Kraft accelerator launches patient-focused pilot program

...LUNGevity Foundation, the Metastatic Breast Cancer Alliance, the Multiple Myeloma Research Foundation (MMRF), the Pancreatic Cancer Action Network...
...2017) . Harvard Business School, Boston, Mass. Business: Cancer Elizabeth S. Eaton Harvard LUNGevity Foundation Multiple Myeloma Research Foundation (MMRF) Pancreatic Cancer Action Network...
BioCentury | May 14, 2018
Company News

Kraft Accelerator launches patient-focused pilot program

...LUNGevity Foundation, the Metastatic Breast Cancer Alliance, the Multiple Myeloma Research Foundation (MMRF), the Pancreatic Cancer Action Network...
...the right patients (see BioCentury, Dec. 15, 2017) . Elizabeth S. Eaton Harvard LUNGevity Foundation Multiple Myeloma Research Foundation (MMRF) Pancreatic Cancer Action Network...
BioCentury | Jan 11, 2018
Translation in Brief

Quality over quantity

...Balachandran’s team plans to investigate whether neoantigen quality scores predict response to immunotherapies in the Pancreatic Cancer Action Network’s...
...survivors of pancreatic cancer.” Nature (2017) Karen Tkach Tuzman, Associate Editor BioNTech AG Genentech Inc. Memorial Sloan Kettering Cancer Center Pancreatic Cancer Action Network Roche CD8 Human...
BioCentury | Dec 15, 2017
Product Development

Patient-powered precision

...began by analyzing the patient journey from diagnosis to treatment in collaboration with MMRF, the Pancreatic Cancer Action Network...
...Scottsdale, Ariz. National Brain Tumor Society, Newton, Mass. National Foundation for Cancer Research, Bethesda, Md. Pancreatic Cancer Action Network...
BioCentury | Nov 10, 2017
Emerging Company Profile

Computing care

...through research partnerships. Its platform will be used to match patients to treatments in The Pancreatic Cancer Action Network’s...
...Inc. (NASDAQ:FMI), Cambridge, Mass. Groupon Inc. (NASDAQ:GRPN), Chicago, Ill. National Cancer Institute (NCI), Bethesda, Md. Pancreatic Cancer Action Network...
Items per page:
1 - 10 of 14
BioCentury | Oct 17, 2020
Product Development

How the PanCAN master protocol could promote innovation in pancreatic cancer

...more patients, in the process. On Tuesday, the Pancreatic Cancer Action Network...
...real value to companies,” said Fleshman. Lauren Martz Tyme Inc. Pancreatic Cancer Action Network Cancer Pancreatic...
BioCentury | Apr 26, 2019
Product Development

For patients’ sake, collaborate already

...Leukemia & Lymphoma Society (LLS), Rye Brooke, N.Y. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Pancreatic Cancer Action Network...
BioCentury | Mar 23, 2019
Tools & Techniques

A frequentist and a Bayesian walk into a trial

...way we write regulatory policy.” I-SPY, the Global Coalition for Adaptive Research (GCAR) and the Pancreatic Cancer Action Network...
...Inc., Cambridge, Mass. Innovative Medicines Initiative (IMI), Brussels, Belgium Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pancreatic Cancer Action Network...
...endothelial growth factor receptor 2 Karen Tkach Tuzman, Associate Editor Bayer AG European Medicines Agency (EMA) Innovative Medicines Initiative (IMI) Pancreatic Cancer Action Network U.S...
BioCentury | Mar 15, 2019
Product Development

Broadening the PARP playing field

...POLO trial results as well,” he added. Victoria Manax, CMO at the patient advocacy organization Pancreatic Cancer Action Network...
BioCentury | Sep 21, 2018
Tools & Techniques

Precision for pancreatic cancer

...free-of-charge and match them to existing trials. The platform has a five-day turnaround, Rhodes said. Pancreatic Cancer Action Network...
...N.J. National Center for Tumor Diseases Heidelberg, Heidelberg, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pancreatic Cancer Action Network...
...TMEM66) - Store-operated calcium entry associated regulatory factor Allison Johnson, Staff Writer Cold Spring Harbor Laboratory Dana-Farber Cancer Institute Pancreatic Cancer Action Network Strata...
BioCentury | May 18, 2018
Company News

Kraft accelerator launches patient-focused pilot program

...LUNGevity Foundation, the Metastatic Breast Cancer Alliance, the Multiple Myeloma Research Foundation (MMRF), the Pancreatic Cancer Action Network...
...2017) . Harvard Business School, Boston, Mass. Business: Cancer Elizabeth S. Eaton Harvard LUNGevity Foundation Multiple Myeloma Research Foundation (MMRF) Pancreatic Cancer Action Network...
BioCentury | May 14, 2018
Company News

Kraft Accelerator launches patient-focused pilot program

...LUNGevity Foundation, the Metastatic Breast Cancer Alliance, the Multiple Myeloma Research Foundation (MMRF), the Pancreatic Cancer Action Network...
...the right patients (see BioCentury, Dec. 15, 2017) . Elizabeth S. Eaton Harvard LUNGevity Foundation Multiple Myeloma Research Foundation (MMRF) Pancreatic Cancer Action Network...
BioCentury | Jan 11, 2018
Translation in Brief

Quality over quantity

...Balachandran’s team plans to investigate whether neoantigen quality scores predict response to immunotherapies in the Pancreatic Cancer Action Network’s...
...survivors of pancreatic cancer.” Nature (2017) Karen Tkach Tuzman, Associate Editor BioNTech AG Genentech Inc. Memorial Sloan Kettering Cancer Center Pancreatic Cancer Action Network Roche CD8 Human...
BioCentury | Dec 15, 2017
Product Development

Patient-powered precision

...began by analyzing the patient journey from diagnosis to treatment in collaboration with MMRF, the Pancreatic Cancer Action Network...
...Scottsdale, Ariz. National Brain Tumor Society, Newton, Mass. National Foundation for Cancer Research, Bethesda, Md. Pancreatic Cancer Action Network...
BioCentury | Nov 10, 2017
Emerging Company Profile

Computing care

...through research partnerships. Its platform will be used to match patients to treatments in The Pancreatic Cancer Action Network’s...
...Inc. (NASDAQ:FMI), Cambridge, Mass. Groupon Inc. (NASDAQ:GRPN), Chicago, Ill. National Cancer Institute (NCI), Bethesda, Md. Pancreatic Cancer Action Network...
Items per page:
1 - 10 of 14